Tertiary-butyl acetate metabolism, toxicity, and human health considerations

Toxicological and Environmental Chemistry

Volumn 88, Issue 3, 2006, Pages 405-421

  Cruzan, George ^a   Kirkpatrick, Daniel ^b  

^a ToxWorks   (United States)

^b WIL RESEARCH LABORATORIES   (United States)

Author keywords

Genotoxicity; Metabolism; Subacute toxicity; Tertiary butyl acetate

Indexed keywords

ABSORPTION; ADHESIVES; HEALTH CARE; HYDROLYSIS; HYDROXYLATION; INK; METABOLISM; RADIOACTIVITY; RISK ASSESSMENT; TOXICITY;

GENOTOXICITY; INDUSTRIAL COATINGS; SUBACUTE TOXICITY; TERTIARY-BUTYL ACETATE;

ORGANIC COMPOUNDS;

ACETATE; BIOASSAY; CONCENTRATION (COMPOSITION); GENOTOXICITY; HAZARD ASSESSMENT; METABOLISM; OCCUPATIONAL EXPOSURE; POLLUTION EFFECT; RISK ASSESSMENT;

BACTERIA (MICROORGANISMS); ESCHERICHIA COLI; SALMONELLA TYPHIMURIUM;

EID: 33746874825     PISSN: 02772248     EISSN: 10290486     Source Type: Journal    
DOI: 10.1080/02772240600727428     Document Type: Article

References (30)

1. Budroe JD, Brown JP, Salsmon AG, Marty MA. Acute toxicity and cancer risk assessment values for tert-butyl acetate. Reg. Toxicol. Pharmacol. 2004;40:168-176.
2. Schmid W. The micronucleus test for cytogenetic analysis. In: Hollander A, editor. Chemical Mutagens, Principles and Methods for their Detection. Vol. 4. New York: Plenum Press; 1976. p 31.
3. ISCN. In: Harnden DG, Klinger HP, editors. An International System for Human Cytogenetic Nomenclature. Basel: S. Karger AG; 1985.
4. Gibbons JD. Nonparametric Statistical Inference. 2nd edn. New York: Marcel Dekker; 1985.
5. Bartlett MS. Properties of sufficiency and statistical tests. Proc. Roy. Soc. Series A 1937;160:268-282.
6. Dunnett CW. New tables for multiple comparisons with controls. Biometrics 1964;20:482.
7. Dunnett CW. A multiple comparison procedure for comparing several treatments with a control. J. Am. Stat. Assoc. 1995;50:1096.
8. Williams DA. A test for differences between treatment means when several dose levels are compared with a zero dose control. Biometrics 1971;27:103-117.
9. Williams DA. The comparison of several dose levels with a zero dose control. Biometrics 1972;28:519-531.
10. Levene H. Robust Tests for Equality of Variances. In: Olkin I, Ghurye SG, Hoeffding W, Madow WG, Mann HB, editors. Contributions to probability and statistics. Stanford (CA): Stanford University Press; 1960. pp 278-292.
11. Royston JP. An extension of Shapiro and Wilk's W test for normality in large samples. Applied Statistics 1982;31:115-124.
12. Snedecor GW, Cochran WG. One way classifications; Analysis of Variance. Statistical Methods. 7th edn. Ames, IA: The Iowa State University Press; 1980. pp 215-237.
13. Fisher RA. The Exact Treatment of 2 x 2 Table.Statistical Methods for Research Workers. New York: Hafner Publishing Company; 1973.
14. McGregor DB, Cruzan G, Callander RD, May K, Banton M. The mutagenicity testing of tertiary-butyl alcohol, tertiary-butyl acetate™ and methyl tertiary-butyl ether in Salmonella typhimurium. Mutat. Res. 2005;565:181-189.
15. IBT. Toxicity Studies on TFA-168. tert-butyl acetate. Performed by Industrial Bio-Test Laboratories, Inc. Northbrook, Illinois for Albemarle Corporation, Baton Rouge, LA, Submitted to US EPA, April 23, 1994 (EPA/OTS Doc # 86940000229, NTIS/OTS0556824);1958.
16. Stillmeadow, Inc. tert-Butyl acetate. Volume V. Acute inhalation toxicity study in rats. Sponsored by MB Research Laboratories, Inc. for ARCO Chemical Company, Newtown Square, PA. Submitted to US EPA November 4, 1997 (EPA/OTS Doc # 87980000002; NTIS/OTS0573684-1);1997.
17. Groth G, Freundt KJ. Inhaled tert-butyl acetate and its metabolite tert-butyl alcohol accumulate in the blood during exposure. Human Exp. Toxicol. 1994;13:478-480.
18. Williams-Hill D, Spears CP, Prakash S, Olah GA, Shamma T, Moin T, Kim LY, Hill CK. Mutagenicity studies of methyl-tert-butylether using Ames tester strain TA102. Mutat. Res. 1999;446:15-21.
19. Dillon D, Coombes R, Zeiger E. The effectiveness of Salmonella strains TA100, TA102 and TA104 for detecting mutagenicity of some aldehydes and peroxides. Mutagenesis 1998;13:19-36.
20. Tang G, Wang J, Zhuang Z. Cytotoxicity and genotoxicity of methyl tert-butyl ether and its metabolite to human leukemia cells. Chin. J. Prev. Med. 1997;31:334-337.
21. McGregor D. Methyl tertiary-Butyl Ether: Studies for Potential Human Health Hazards. Crit. Rev. Toxicol. 2006;36:319-358.
22. McGregor DB, Edwards I, Riach CG, Cattanach P, Martin R, Mitchell A, Caspary WJ. Studies of an S9-based metabolic activation system used in the mouse lymphoma L5178Y cell mutation assay. Mutagenesis 1988;3:485-490.
23. 1 mice (drinking water studies). National Toxicology Program Report TR-436. NTIS Publication No. PB96-162748;1995.
24. McGregor D, Hard GC. Renal tubule tumor induction by tertiary-butyl alcohol. Toxicol. Sci. 2001;61:1-3.
25. Trump BF, Jones TW, Hatfield BM. The biology of the kidney. In: Mehlman MA, Hemstreet GP, Thorpe JJ, Weaver NK, editors. Advances in Modern Environmental Toxicology, Vol. 7, Renal Effects of Petroleum Hydrocarbons. Princeton: Princeton Scientific Publishers; 1984. pp 27-49.
26. 2u-globulin, hyaline droplet nephropathy, and tubule neoplasia in the kidneys of male rats. Environ. Health Perspect. 1993;99:313-349.
27. Hard GC, Whysner J, English JC, Zang E, Williams GM. Relationship of hydroquinone-associated rat renal tumors with spontaneous chronic progressive nephropathy. Toxicol. Pathol. 1997;25:132-143.
28. Hard GC. Mechanisms of chemically induced renal carcinogenesis in the laboratory rodent. Toxicol. Pathol. 1998;26:104-112.
29. 1 mice. National Toxicology Program Report TOX-53;1997.
30. Melby Jr EC, Akman NH. CRC Handbook of Laboratory Animal Science. 1st edn. Vol. I. Boca Raton, FL: CRC Press; 1994. p 263.